Digitalising NHS patient data could be the key to a healthcare revolution

A recent Ernst & Young (EY) report presents a framework for the efficient and ethical use of NHS data, which it describes as ‘a treasure trove of information detailing health, wellness, illness and the associated care pathways.’ A recent Ernst & Young (EY) report presents a framework for the efficient and ethical use of NHS data, which it describes as ‘a treasure trove of information detailing health, wellness, illness and the associated care pathways.’

According to their estimates, genomic data currently held by the NHS could generate £5 billion each year and provide healthcare benefits worth £4.6 billion to patients.

The report is optimistic about the possible benefits of using NHS data for every stakeholder in the healthcare ecosystem. There is immense potential to streamline and personalise patient care, facilitate innovation in the pharmaceutical industry, and cut operational costs for the NHS, according to the report.